Answers are grounded in this paper and cite their sources.
Review explores cognitive symptoms and prefrontal dopamine dysfunction in Parkinson's disease, highlighting therapeutic targets to prevent progression to dementia.
Cognitive dysfunction is a common symptom of Parkinson's disease (PD) that causes significant morbidity and mortality. The severity of these symptoms ranges from minor executive symptoms to frank dementia involving multiple domains. In the present review, we will concentrate on the aspects of cognitive impairment associated with prefrontal dopaminergic dysfunction, seen in non-demented patients with PD. These symptoms include executive dysfunction and disorders of thought, such as hallucinations and psychosis. Such symptoms may go on to predict dementia related to PD, which involves amnestic dysfunction and is typically seen later in the disease. Cognitive symptoms are associated with dysfunction in cholinergic circuits, in addition to the abnormalities in the prefrontal dopaminergic system. These circuits can be carefully studied and evaluated in PD, and could be leveraged to treat difficult clinical problems related to cognitive symptoms of PD.
No takes yet. Share an insight, caveat, or question.
Narayanan et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: